STU 3 Candidate

This page is part of the FHIR Specification (v1.4.0: STU 3 Ballot 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

Detectedissue-example

This is the narrative for the resource. See also the XML or JSON format. This example conforms to the profile DetectedIssue.

Severity: High - Risk of internal bleeding

Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.

500 mg Acetaminophen tablet 1/day, PRN since 2010
Warfarin 1 MG TAB prescribed Jan. 5, 2014

Mitigation: Jan 5, 2014 by Dr. Adam Careful:

Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.